Schizophrenia Research

Title Publication Date Language Citations
The MATRICS initiative: developing a consensus cognitive battery for clinical trials2004/12/01English177
Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia2005/10/01English176
The MCCB impairment profile for schizophrenia outpatients: Results from the MATRICS psychometric and standardization study2011/03/01English176
Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: A meta-analysis2007/11/01English175
Facial emotion recognition in schizophrenia:When and why does it go awry?2007/08/01English174
Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review2008/04/01English173
Mental state attribution, neurocognitive functioning, and psychopathology: What predicts poor social competence in schizophrenia best?2007/05/01English173
Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: Implications for genesis of neurodevelopmental disorders2008/02/01English173
World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia2008/03/01English172
The effects of individually tailored formulation-based cognitive behavioural therapy in auditory hallucinations and delusions: A meta-analysis2014/06/01English172
High dose D-serine in the treatment of schizophrenia2010/08/01English172
A systematic review of the antipsychotic properties of cannabidiol in humans2015/03/01English171
Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study2010/02/01English171
A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases1994/04/01English171
Reductions in frontal, temporal and parietal volume associated with the onset of psychosis2008/12/01English170
Community screening for psychotic-like experiences and other putative antecedents of schizophrenia in children aged 9–12 years2007/02/01English170
Aberrant salience network (bilateral insula and anterior cingulate cortex) connectivity during information processing in schizophrenia2010/11/01English169
Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment2010/08/01English169
Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis2013/12/01English167
Peripheral oxytocin is associated with reduced symptom severity in schizophrenia2010/12/01English167
Determinants of everyday outcomes in schizophrenia: The influences of cognitive impairment, functional capacity, and symptoms2009/11/01English167
Suicidal risk during treatment with clozapine: a meta-analysis2005/03/01English167
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use2007/08/01English166
Duration of untreated psychosis and negative symptoms — A systematic review and meta-analysis of individual patient data2012/12/01English166
The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China2015/12/01English166
Neurocognitive predictors of functional outcome two to 13years after identification as ultra-high risk for psychosis2011/10/01English165
Does antipsychotic polypharmacy increase the risk for metabolic syndrome?2007/01/01English164
Childhood infection and adult schizophrenia: A meta-analysis of population-based studies2012/08/01English164
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 12008/04/01English164
Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology?2016/09/01English164